Related Experiment Video
Updated: Feb 3, 2026

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
Published on: January 6, 2023
S100 Proteins in Acute Myeloid Leukemia
Annette K Brenner1, Øystein Bruserud1
1Department of Medicine, Haukeland University Hospital, P.O. Box 1400, 5021 Bergen, Norway; Section for Hematology, Department of Clinical Science, University of Bergen, P.O. Box 7804, 5020 Bergen, Norway.
S100 proteins are often altered in cancer and may serve as biomarkers for acute myeloid leukemia (AML). A panel of S100 proteins could offer prognostic value and potential therapeutic targets in AML.
Area of Science:
- Oncology
- Hematology
- Molecular Biology
Background:
- The S100 protein family comprises 20 members with diverse roles in cellular processes.
- S100 proteins are frequently dysregulated in various cancers, acting as biomarkers for disease progression and prognosis.
- Acute myeloid leukemia (AML) is an aggressive hematologic malignancy characterized by the accumulation of immature myeloblasts.
Purpose of the Study:
- To review the role of dysregulated S100 protein family members in AML.
- To explore the potential of S100 proteins as biomarkers for leukemogenesis and prognosis in AML.
- To discuss S100 proteins as potential therapeutic targets in AML.
Main Methods:
- Literature review focusing on S100 protein family members in AML.
- Analysis of S100 protein dysregulation and its consequences in the context of AML.
- Evaluation of S100 proteins as prognostic biomarkers and therapeutic targets.
Main Results:
- S100 proteins are commonly dysregulated in AML, similar to other cancers.
- S100 proteins are implicated in maintaining the leukemic phenotype in AML.
- Specific S100 protein signatures may exist for particular AML subgroups.
Conclusions:
- S100 proteins show potential as biomarkers for leukemogenesis and prognosis in AML.
- A panel of S100 proteins is likely optimal for prognostic purposes in AML.
- Targeting specific S100 proteins may offer avenues for personalized therapy in AML.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
06:33Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...